Pathstone Family Office’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-90	Closed	–	–	865
2020 Q1	$0	Buy	+90	New	–	﹤0.01%	801